Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.710
+0.020 (0.74%)
Mar 6, 2026, 4:00 PM EST - Market closed
Genelux Employees
Genelux had 24 employees as of December 31, 2024. The number of employees increased by 1 or 4.35% compared to the previous year.
Employees
24
Change (1Y)
1
Growth (1Y)
4.35%
Revenue / Employee
n/a
Profits / Employee
-$1,328,083
Market Cap
120.01M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24 | 1 | 4.35% |
| Dec 31, 2023 | 23 | 8 | 53.33% |
| Dec 31, 2022 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| Agenus | 316 |
| Inovio Pharmaceuticals | 134 |
| Tenaya Therapeutics | 97 |
| Precision BioSciences | 67 |
| Spero Therapeutics | 32 |
| Cassava Sciences | 30 |
| Oncolytics Biotech | 28 |
GNLX News
- 7 weeks ago - Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners - GlobeNewsWire
- 2 months ago - Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Genelux Corporation Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 2 months ago - Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer - GlobeNewsWire
- 4 months ago - Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 7 months ago - Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire
- 8 months ago - Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development - GlobeNewsWire
- 10 months ago - Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates - GlobeNewsWire